Nektar Therapeutics (NKTR) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Nektar Therapeutics (NKTR) over the last 13 years, with Q3 2025 value amounting to -$1.87.
- Nektar Therapeutics' EPS (Weighted Average and Diluted) rose 2969.92% to -$1.87 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.63, marking a year-over-year increase of 15314.79%. This contributed to the annual value of -$0.58 for FY2024, which is 6009.91% up from last year.
- According to the latest figures from Q3 2025, Nektar Therapeutics' EPS (Weighted Average and Diluted) is -$1.87, which was up 2969.92% from -$2.95 recorded in Q2 2025.
- In the past 5 years, Nektar Therapeutics' EPS (Weighted Average and Diluted) registered a high of $0.04 during Q4 2024, and its lowest value of -$3.76 during Q2 2024.
- In the last 5 years, Nektar Therapeutics' EPS (Weighted Average and Diluted) had a median value of -$0.68 in 2021 and averaged -$0.94.
- The largest annual percentage gain for Nektar Therapeutics' EPS (Weighted Average and Diluted) in the last 5 years was 11598.84% (2024), contrasted with its biggest fall of 129259.26% (2024).
- Quarter analysis of 5 years shows Nektar Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.8 in 2021, then soared by 60.07% to -$0.32 in 2022, then skyrocketed by 31.25% to -$0.22 in 2023, then surged by 115.99% to $0.04 in 2024, then crashed by 5416.37% to -$1.87 in 2025.
- Its last three reported values are -$1.87 in Q3 2025, -$2.95 for Q2 2025, and -$0.24 during Q1 2025.